Sharl Azar

737 total citations
3 papers, 546 citations indexed

About

Sharl Azar is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sharl Azar has authored 3 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Genetics and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Sharl Azar's work include Hemoglobinopathies and Related Disorders (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Blood groups and transfusion (1 paper). Sharl Azar is often cited by papers focused on Hemoglobinopathies and Related Disorders (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Blood groups and transfusion (1 paper). Sharl Azar collaborates with scholars based in United States and India. Sharl Azar's co-authors include Erick Jacobson‐Dunlop, Amy Harlow, Claudia Le, F. Stephen Hodi, Ajia Town, Andrea Warrick, Christopher L. Corless, Robert B. West, Carol Beadling and Janice Patterson and has published in prestigious journals such as Blood, Clinical Cancer Research and Medical Clinics of North America.

In The Last Decade

Sharl Azar

2 papers receiving 538 citations

Peers

Sharl Azar
Meredith Pelster United States
A. Y. Bedikian United States
Janice Shipe-Spotloe United States
Mayumi Sugita United States
Meredith Pelster United States
Sharl Azar
Citations per year, relative to Sharl Azar Sharl Azar (= 1×) peers Meredith Pelster

Countries citing papers authored by Sharl Azar

Since Specialization
Citations

This map shows the geographic impact of Sharl Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharl Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharl Azar more than expected).

Fields of papers citing papers by Sharl Azar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharl Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharl Azar. The network helps show where Sharl Azar may publish in the future.

Co-authorship network of co-authors of Sharl Azar

This figure shows the co-authorship network connecting the top 25 collaborators of Sharl Azar. A scholar is included among the top collaborators of Sharl Azar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharl Azar. Sharl Azar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Brown, T. T., et al.. (2024). Exploring the Patient Perspective of Gene Therapy for Sickle Cell Disease. Blood. 144(Supplement 1). 4999–4999.
2.
Azar, Sharl & Trisha E. Wong. (2016). Sickle Cell Disease. Medical Clinics of North America. 101(2). 375–393. 55 indexed citations
3.
Beadling, Carol, Erick Jacobson‐Dunlop, F. Stephen Hodi, et al.. (2008). KIT Gene Mutations and Copy Number in Melanoma Subtypes. Clinical Cancer Research. 14(21). 6821–6828. 491 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026